ReP USP - Resultado da busca

Artigo de periodico
Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products (2024)
Yousef, Malaz ; Park, Chulhun ; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: MEDICAÇÃO ORAL, VASOS LINFÁTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products. AAPS PharmSciTech, v. 25, p. 1-9 art. 187, 2024Tradução . . Disponível em: https://dx.doi.org/10.1208/s12249-024-02866-y. Acesso em: 28 out. 2024.
APA
Yousef, M., Park, C., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2024). Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products. AAPS PharmSciTech, 25, 1-9 art. 187. doi:10.1208/s12249-024-02866-y
NLM
Yousef M, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products [Internet]. AAPS PharmSciTech. 2024 ; 25 1-9 art. 187.[citado 2024 out. 28 ] Available from: https://dx.doi.org/10.1208/s12249-024-02866-y
Vancouver
Yousef M, Park C, Bou-Chacra NA, Davies NM, Löbenberg R. Novel first-generation dissolution models to investigate the release and uptake of oral Lymphotropic drug products [Internet]. AAPS PharmSciTech. 2024 ; 25 1-9 art. 187.[citado 2024 out. 28 ] Available from: https://dx.doi.org/10.1208/s12249-024-02866-y
Artigo de periodico
Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice (2023)
Gonçalves, Debora de Souza; Yukuyama, Megumi Nishitani ; Miyagi, Mariana Yasue Saito ; Silva, Tamara Juliane Vieira; Lameu, Claudiana ; Bou-Chacra, Nadia Araci ; Araujo, Gabriel Lima Barros de
Source: Journal of Cluster Science. Unidades: FCF, IQ
Subjects: ANTI-HELMÍNTICOS, NEOPLASIAS PULMONARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Debora de Souza et al. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, v. 34, n. 1, p. 262-272, 2023Tradução . . Disponível em: https://doi.org/10.1007/s10876-022-02220-x. Acesso em: 28 out. 2024.
APA
Gonçalves, D. de S., Yukuyama, M. N., Miyagi, M. Y. S., Silva, T. J. V., Lameu, C., Bou-Chacra, N. A., & Araujo, G. L. B. de. (2023). Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice. Journal of Cluster Science, 34( 1), 262-272. doi:10.1007/s10876-022-02220-x
NLM
Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
Vancouver
Gonçalves D de S, Yukuyama MN, Miyagi MYS, Silva TJV, Lameu C, Bou-Chacra NA, Araujo GLB de. Revisiting flubendazole through nanocrystal technology: statistical design, characterization and its potential inhibitory effect on xenografted lung tumor progression in mice [Internet]. Journal of Cluster Science. 2023 ; 34( 1): 262-272.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s10876-022-02220-x
Artigo de periodico
Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications (2023)
Yousef, Malaz ; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Applied Chemical Engineering. Unidade: FCF
Subjects: LIPOPROTEÍNAS, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, v. 6, n. 2, p. 1-7, 2023Tradução . . Disponível em: https://doi.org/10.24294/ace.v6i2.2202. Acesso em: 28 out. 2024.
APA
Yousef, M., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2023). Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications. Applied Chemical Engineering, 6( 2), 1-7. doi:10.24294/ace.v6i2.2202
NLM
Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 out. 28 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
Vancouver
Yousef M, Bou-Chacra NA, Davies NM, Löbenberg R. Lipoproteins within the lymphatic system: Insights into health, disease, and therapeutic implications [Internet]. Applied Chemical Engineering. 2023 ; 6( 2): 1-7.[citado 2024 out. 28 ] Available from: https://doi.org/10.24294/ace.v6i2.2202
Artigo de periodico
In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium (2022)
Hajjar, Braa; Zuo, Jieyu; Park, Chulhun; Azarmi, Shirzad; Silva, Daniela Amaral; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: ANTI-INFLAMATÓRIOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAJJAR, Braa et al. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, v. 23, p. 1-9 art. 102, 2022Tradução . . Disponível em: https://doi.org/10.1208/s12249-022-02258-0. Acesso em: 28 out. 2024.
APA
Hajjar, B., Zuo, J., Park, C., Azarmi, S., Silva, D. A., Bou-Chacra, N. A., & Löbenberg, R. (2022). In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium. AAPS PharmSciTech, 23, 1-9 art. 102. doi:10.1208/s12249-022-02258-0
NLM
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Vancouver
Hajjar B, Zuo J, Park C, Azarmi S, Silva DA, Bou-Chacra NA, Löbenberg R. In vitro evaluation of a foamable microemulsion towards an improved topical delivery of diclofenac sodium [Internet]. AAPS PharmSciTech. 2022 ; 23 1-9 art. 102.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12249-022-02258-0
Artigo de periodico
Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development (2022)
Yousef, Malaz ; Park, Chulhun; Le, Tyson S; Bou-Chacra, Nadia Araci ; Davies, Neal M; Löbenberg, Raimar
Source: Dissolutiom Technologies. Unidade: FCF
Subjects: FÁRMACOS, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, v. 29, n. 2, p. 86-93, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P86. Acesso em: 28 out. 2024.
APA
Yousef, M., Park, C., Le, T. S., Bou-Chacra, N. A., Davies, N. M., & Löbenberg, R. (2022). Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development. Dissolutiom Technologies, 29( 2), 86-93. doi:10.14227/DT290222P86
NLM
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT290222P86
Vancouver
Yousef M, Park C, Le TS, Bou-Chacra NA, Davies NM, Löbenberg R. Simulated lymphatic fluid for in-vitro assessment in pharmaceutical development [Internet]. Dissolutiom Technologies. 2022 ; 29( 2): 86-93.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT290222P86
Artigo de periodico
Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions (2022)
Silva, Daniela Amaral ; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 28 out. 2024.
APA
Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
NLM
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT290222P62
Vancouver
Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT290222P62
Artigo de periodico
Innovative drug delivery systems for leprosy treatment (2022)
Rocha, Nataly Paredes da ; Barbosa, Eduardo José ; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Source: Indian Journal of Dermatology. Unidade: FCF
Subjects: HANSENÍASE, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Nataly Paredes da et al. Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, v. 88, n. 3, p. 437-442, 2022Tradução . . Disponível em: https://doi.org/10.25259/ijdvl_1119_20. Acesso em: 28 out. 2024.
APA
Rocha, N. P. da, Barbosa, E. J., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2022). Innovative drug delivery systems for leprosy treatment. Indian Journal of Dermatology, 88( 3), 437-442. doi:10.25259/ijdvl_1119_20
NLM
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 out. 28 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
Vancouver
Rocha NP da, Barbosa EJ, Araujo GLB de, Bou-Chacra NA. Innovative drug delivery systems for leprosy treatment [Internet]. Indian Journal of Dermatology. 2022 ; 88( 3): 437-442.[citado 2024 out. 28 ] Available from: https://doi.org/10.25259/ijdvl_1119_20
Artigo de periodico
A BCS-based biowaiver approach using biphasic dissolution test (2021)
Silva, Daniela Amaral; Melo, Katherine Jasmine Curo; Davies, Neal M; Bou-Chacra, Nadia Araci ; Ferraz, Humberto Gomes ; Löbenberg, Raimar
Source: Dissolution Technology. Unidade: FCF
Subjects: BIOEQUIVALÊNCIA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, v. 28, n. 4, p. 40-48, 2021Tradução . . Disponível em: https://doi.org/10.14227/DT280421P40. Acesso em: 28 out. 2024.
APA
Silva, D. A., Melo, K. J. C., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2021). A BCS-based biowaiver approach using biphasic dissolution test. Dissolution Technology, 28( 4), 40-48. doi:10.14227/DT280421P40
NLM
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT280421P40
Vancouver
Silva DA, Melo KJC, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. A BCS-based biowaiver approach using biphasic dissolution test [Internet]. Dissolution Technology. 2021 ; 28( 4): 40-48.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT280421P40
Artigo de periodico
Nanoemulsions containing plant oils: how do they influence hair treatment? (2021)
Tamashiro, Fernanda Leika ; Yukuyama, Megumi Nishitani ; Velasco, Maria Valéria Robles ; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Source: International Journal of Cosmetic Science. Unidade: FCF
Subjects: ÓLEOS VEGETAIS, CABELO, SURFACTANTES, EMULSÕES COSMÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAMASHIRO, Fernanda Leika et al. Nanoemulsions containing plant oils: how do they influence hair treatment?. International Journal of Cosmetic Science, v. 43, n. 2, p. 136–143, 2021Tradução . . Disponível em: https://doi.org/10.1111/ics.12667. Acesso em: 28 out. 2024.
APA
Tamashiro, F. L., Yukuyama, M. N., Velasco, M. V. R., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2021). Nanoemulsions containing plant oils: how do they influence hair treatment? International Journal of Cosmetic Science, 43( 2), 136–143. doi:10.1111/ics.12667
NLM
Tamashiro FL, Yukuyama MN, Velasco MVR, Araujo GLB de, Bou-Chacra NA. Nanoemulsions containing plant oils: how do they influence hair treatment? [Internet]. International Journal of Cosmetic Science. 2021 ; 43( 2): 136–143.[citado 2024 out. 28 ] Available from: https://doi.org/10.1111/ics.12667
Vancouver
Tamashiro FL, Yukuyama MN, Velasco MVR, Araujo GLB de, Bou-Chacra NA. Nanoemulsions containing plant oils: how do they influence hair treatment? [Internet]. International Journal of Cosmetic Science. 2021 ; 43( 2): 136–143.[citado 2024 out. 28 ] Available from: https://doi.org/10.1111/ics.12667
Artigo de periodico
Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics (2021)
Zuo, Jieyu; Park, Chulhun; Kung, Janice Yu Chen ; Bou-Chacra, Nadia Araci ; Doschak, Michael ; Löbenberg, Raimar
Source: Pharmaceutical Research. Unidade: FCF
Subjects: MEDICINA ALTERNATIVA, FITOTERAPIA, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZUO, Jieyu et al. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics. Pharmaceutical Research, v. 38, n. 2, p. 199-211, 2021Tradução . . Disponível em: https://doi.org/10.1007/s11095-021-03007-x. Acesso em: 28 out. 2024.
APA
Zuo, J., Park, C., Kung, J. Y. C., Bou-Chacra, N. A., Doschak, M., & Löbenberg, R. (2021). Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics. Pharmaceutical Research, 38( 2), 199-211. doi:10.1007/s11095-021-03007-x
NLM
Zuo J, Park C, Kung JYC, Bou-Chacra NA, Doschak M, Löbenberg R. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics [Internet]. Pharmaceutical Research. 2021 ; 38( 2): 199-211.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s11095-021-03007-x
Vancouver
Zuo J, Park C, Kung JYC, Bou-Chacra NA, Doschak M, Löbenberg R. Traditional chinese medicine “Pill”, an ancient dosage Form with surprising modern pharmaceutical characteristics [Internet]. Pharmaceutical Research. 2021 ; 38( 2): 199-211.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s11095-021-03007-x
Artigo de periodico
Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics (2021)
Repin, Ilia Alekseevich; Loebenberg, Raimar ; DiBella, John; Conceição, António C. L; Piedade, Manuel E. Minas da ; Ferraz, Humberto Gomes ; Issa, Michele Georges ; Bou-Chacra, Nadia Araci ; Ermida, Catharine Fonseca Martins; Araujo, Gabriel Lima Barros de
Source: AAPS PharmSciTech. Unidade: FCF
Subjects: POLIMORFISMO, FARMACOCINÉTICA, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REPIN, Ilia Alekseevich et al. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, v. 22, p. 1-11 art. 54, 2021Tradução . . Disponível em: https://doi.org/10.1208/s12249-021-01923-0. Acesso em: 28 out. 2024.
APA
Repin, I. A., Loebenberg, R., DiBella, J., Conceição, A. C. L., Piedade, M. E. M. da, Ferraz, H. G., et al. (2021). Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics. AAPS PharmSciTech, 22, 1-11 art. 54. doi:10.1208/s12249-021-01923-0
NLM
Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12249-021-01923-0
Vancouver
Repin IA, Loebenberg R, DiBella J, Conceição ACL, Piedade MEM da, Ferraz HG, Issa MG, Bou-Chacra NA, Ermida CFM, Araujo GLB de. Exploratory study on lercanidipine hydrochloride polymorphism: ph-dependent solubility behavior and simulation of its impact on pharmacokinetics [Internet]. AAPS PharmSciTech. 2021 ; 22 1-11 art. 54.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12249-021-01923-0
Artigo de periodico
Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate (2021)
Rocha, Emmily Dantas; Ferreira, Márcia Regina Spuri; Santos Neto, Edson dos; Barbosa, Eduardo José ; Löbenberg, Raimar ; Lourenço, Felipe Rebello ; Bou-Chacra, Nadia Araci
Source: Journal of Pharmaceutical Innovation. Unidades: FCF, EACH
Subjects: INFECÇÕES OCULARES, PSEUDOMONAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROCHA, Emmily Dantas et al. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate. Journal of Pharmaceutical Innovation, v. 16, n. 1, p. 125–135, 2021Tradução . . Disponível em: https://doi.org/10.1007/s12247-020-09427-3. Acesso em: 28 out. 2024.
APA
Rocha, E. D., Ferreira, M. R. S., Santos Neto, E. dos, Barbosa, E. J., Löbenberg, R., Lourenço, F. R., & Bou-Chacra, N. A. (2021). Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate. Journal of Pharmaceutical Innovation, 16( 1), 125–135. doi:10.1007/s12247-020-09427-3
NLM
Rocha ED, Ferreira MRS, Santos Neto E dos, Barbosa EJ, Löbenberg R, Lourenço FR, Bou-Chacra NA. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate [Internet]. Journal of Pharmaceutical Innovation. 2021 ; 16( 1): 125–135.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s12247-020-09427-3
Vancouver
Rocha ED, Ferreira MRS, Santos Neto E dos, Barbosa EJ, Löbenberg R, Lourenço FR, Bou-Chacra NA. Enhanced In vitro antimicrobial activity of polymyxin B–Coated nanostructured lipid carrier containing dexamethasone acetate [Internet]. Journal of Pharmaceutical Innovation. 2021 ; 16( 1): 125–135.[citado 2024 out. 28 ] Available from: https://doi.org/10.1007/s12247-020-09427-3
Artigo de periodico
Influence of Shea (Butyrospermum parkii) butter, 'TI''O IND. 2' and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy (2020)
Sarruf, Fernanda Daud; Cândido, Thalita Marcílio ; Oliveira, Camila Areias de; Bou-Chacra, Nadia Araci ; Velasco, Maria Valéria Robles ; Baby, André Rolim
Source: Journal of Cosmetic Dermatology. Unidade: FCF
Subjects: MANTEIGA, BATOM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARRUF, Fernanda Daud et al. Influence of Shea (Butyrospermum parkii) butter, 'TI''O IND. 2' and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy. Journal of Cosmetic Dermatology, v. 19, n. 8, p. 2076–2085, 2020Tradução . . Disponível em: https://doi.org/10.1111/jocd.13238. Acesso em: 28 out. 2024.
APA
Sarruf, F. D., Cândido, T. M., Oliveira, C. A. de, Bou-Chacra, N. A., Velasco, M. V. R., & Baby, A. R. (2020). Influence of Shea (Butyrospermum parkii) butter, 'TI''O IND. 2' and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy. Journal of Cosmetic Dermatology, 19( 8), 2076–2085. doi:10.1111/jocd.13238
NLM
Sarruf FD, Cândido TM, Oliveira CA de, Bou-Chacra NA, Velasco MVR, Baby AR. Influence of Shea (Butyrospermum parkii) butter, 'TI''O IND. 2' and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy [Internet]. Journal of Cosmetic Dermatology. 2020 ; 19( 8): 2076–2085.[citado 2024 out. 28 ] Available from: https://doi.org/10.1111/jocd.13238
Vancouver
Sarruf FD, Cândido TM, Oliveira CA de, Bou-Chacra NA, Velasco MVR, Baby AR. Influence of Shea (Butyrospermum parkii) butter, 'TI''O IND. 2' and ethylhexyl methoxycinnamate on physical parameters and in vitro photoprotective efficacy [Internet]. Journal of Cosmetic Dermatology. 2020 ; 19( 8): 2076–2085.[citado 2024 out. 28 ] Available from: https://doi.org/10.1111/jocd.13238
Artigo de periodico
Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses (2020)
Barbosa, Eduardo José ; Gubitoso, Mariana Ribeiro; Bou-Chacra, Nadia Araci ; Byrn, Stephen R; Carvalho, Flavio Machado de Souza ; Araujo, Gabriel Lima Barros de
Source: ChemRxiv. Unidades: FCF, IGC
Subjects: ANTI-HELMÍNTICOS, CORONAVIRUS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBOSA, Eduardo José et al. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv, 2020Tradução . . Disponível em: https://doi.org/10.26434/chemrxiv.12056187. Acesso em: 28 out. 2024.
APA
Barbosa, E. J., Gubitoso, M. R., Bou-Chacra, N. A., Byrn, S. R., Carvalho, F. M. de S., & Araujo, G. L. B. de. (2020). Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses. ChemRxiv. doi:10.26434/chemrxiv.12056187
NLM
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 out. 28 ] Available from: https://doi.org/10.26434/chemrxiv.12056187
Vancouver
Barbosa EJ, Gubitoso MR, Bou-Chacra NA, Byrn SR, Carvalho FM de S, Araujo GLB de. Contribution to the improvement of an oral formulation of niclosamide, an antihelmintic drug candidate for repurposing in SARS-CoV-2 and other viruses [Internet]. ChemRxiv. 2020 ;[citado 2024 out. 28 ] Available from: https://doi.org/10.26434/chemrxiv.12056187
Artigo de periodico
Highly water-soluble orotic acid nanocrystals produced by high-energy milling (2019)
Compri, Jéssica de Cássia Zaghi; Felli, Veni Maria Andres; Lourenço, Felipe Rebello ; Takatsuka, Takayuki; Fotaki, Nikoletta; Löbenberg, Raimar; Bou-Chacra, Nadia Araci ; Araujo, Gabriel Lima Barros de
Source: Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: COMPOSTOS HETEROCÍCLICOS, SOLUBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COMPRI, Jéssica de Cássia Zaghi et al. Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, v. 108, n. 5, p. 1848-1856, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2018.12.015. Acesso em: 28 out. 2024.
APA
Compri, J. de C. Z., Felli, V. M. A., Lourenço, F. R., Takatsuka, T., Fotaki, N., Löbenberg, R., et al. (2019). Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, 108( 5), 1848-1856. doi:10.1016/j.xphs.2018.12.015
NLM
Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 out. 28 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015
Vancouver
Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 out. 28 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015
Artigo de periodico
The Significance of disintegration testing in pharmaceutical development (2018)
Silva, Daniela Amaral; Webster, Gregory K; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: FARMACOCINÉTICA, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Daniela Amaral et al. The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, v. 25, n. 3, p. 30-38, 2018Tradução . . Disponível em: https://doi.org/10.14227/DT250318P30. Acesso em: 28 out. 2024.
APA
Silva, D. A., Webster, G. K., Bou-Chacra, N. A., & Löbenberg, R. (2018). The Significance of disintegration testing in pharmaceutical development. Dissolution Technologies, 25( 3), 30-38. doi:10.14227/DT250318P30
NLM
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT250318P30
Vancouver
Silva DA, Webster GK, Bou-Chacra NA, Löbenberg R. The Significance of disintegration testing in pharmaceutical development [Internet]. Dissolution Technologies. 2018 ; 25( 3): 30-38.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT250318P30
Artigo de periodico
A New Thermodynamically Favored Flubendazole/Maleic Acid Binary Crystal Form: Structure, Energetics, and in Silico PBPK Model-Based Investigation (2018)
Araujo, Gabriel Lima Barros de ; Ferreira, Fábio Furlan; Bernardes, Carlos E. S; Sato, Juliana A. P; Gil, Otavio M; Faria, Dalva Lúcia Araújo de ; Loebenberg, Raimar; Byrn, Stephen R; Ghisleni, Daniela Dal Molim ; Bou-Chacra, Nadia Araci ; Pinto, Terezinha de Jesus Andreoli ; Antônio, Selma G; Ferraz, Humberto Gomes ; Zemlyanov, Dmitry; Goncalves, Debora S; Piedade, Manuel E. Minas da
Source: Crystal Growth & design. Unidades: FCF, IQ
Subjects: DOENÇAS NEGLIGENCIADAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARAUJO, Gabriel Lima Barros de et al. A New Thermodynamically Favored Flubendazole/Maleic Acid Binary Crystal Form: Structure, Energetics, and in Silico PBPK Model-Based Investigation. Crystal Growth & design, v. 18, p. 2377-2386, 2018Tradução . . Disponível em: https://doi.org/10.1021/acs.cgd.7b01807. Acesso em: 28 out. 2024.
APA
Araujo, G. L. B. de, Ferreira, F. F., Bernardes, C. E. S., Sato, J. A. P., Gil, O. M., Faria, D. L. A. de, et al. (2018). A New Thermodynamically Favored Flubendazole/Maleic Acid Binary Crystal Form: Structure, Energetics, and in Silico PBPK Model-Based Investigation. Crystal Growth & design, 18, 2377-2386. doi:10.1021/acs.cgd.7b01807
NLM
Araujo GLB de, Ferreira FF, Bernardes CES, Sato JAP, Gil OM, Faria DLA de, Loebenberg R, Byrn SR, Ghisleni DDM, Bou-Chacra NA, Pinto T de JA, Antônio SG, Ferraz HG, Zemlyanov D, Goncalves DS, Piedade MEM da. A New Thermodynamically Favored Flubendazole/Maleic Acid Binary Crystal Form: Structure, Energetics, and in Silico PBPK Model-Based Investigation [Internet]. Crystal Growth & design. 2018 ; 18 2377-2386.[citado 2024 out. 28 ] Available from: https://doi.org/10.1021/acs.cgd.7b01807
Vancouver
Araujo GLB de, Ferreira FF, Bernardes CES, Sato JAP, Gil OM, Faria DLA de, Loebenberg R, Byrn SR, Ghisleni DDM, Bou-Chacra NA, Pinto T de JA, Antônio SG, Ferraz HG, Zemlyanov D, Goncalves DS, Piedade MEM da. A New Thermodynamically Favored Flubendazole/Maleic Acid Binary Crystal Form: Structure, Energetics, and in Silico PBPK Model-Based Investigation [Internet]. Crystal Growth & design. 2018 ; 18 2377-2386.[citado 2024 out. 28 ] Available from: https://doi.org/10.1021/acs.cgd.7b01807
Artigo de periodico
Evaluation of the rupture test for stability studies of soft-shell capsules (2017)
Bachour, Ghada; Bou-Chacra, Nadia Araci ; Löbenberg, Raimar
Source: Dissolution Technologies. Unidade: FCF
Subjects: CÁPSULAS, RUPTURA DOS MATERIAIS, TESTES ENZIMÁTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BACHOUR, Ghada e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, v. 24, n. 2, p. 16-19, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240217P16. Acesso em: 28 out. 2024.
APA
Bachour, G., Bou-Chacra, N. A., & Löbenberg, R. (2017). Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, 24( 2), 16-19. doi:10.14227/DT240217P16
NLM
Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT240217P16
Vancouver
Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 out. 28 ] Available from: https://doi.org/10.14227/DT240217P16
Artigo de periodico
Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system (2017)
Bou-Chacra, Nadia Araci ; Melo, Katherine Jasmine Curo; Morales, Ivan Andrés Cordova; Stippler, Erika S; Kesisoglou, Filippos; Yazdanian, Mehran; Löbenberg, Raimar
Source: AAPS Journal. Unidade: FCF
Subjects: SOLUBILIDADE, BIOFARMÁCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BOU-CHACRA, Nadia Araci et al. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, v. 19, n. 4, p. 989-1001, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0085-5. Acesso em: 28 out. 2024.
APA
Bou-Chacra, N. A., Melo, K. J. C., Morales, I. A. C., Stippler, E. S., Kesisoglou, F., Yazdanian, M., & Löbenberg, R. (2017). Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system. AAPS Journal, 19( 4), 989-1001. doi:10.1208/s12248-017-0085-5
NLM
Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12248-017-0085-5
Vancouver
Bou-Chacra NA, Melo KJC, Morales IAC, Stippler ES, Kesisoglou F, Yazdanian M, Löbenberg R. Evolution of choice of solubility and dissolution media after two decades of biopharmaceutical classification system [Internet]. AAPS Journal. 2017 ; 19( 4): 989-1001.[citado 2024 out. 28 ] Available from: https://doi.org/10.1208/s12248-017-0085-5
Artigo de periodico
Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases (2017)
Monteiro, Lis Marie; Löbenberg, Raimar; Cotrim, Paulo Cesar; Araujo, Gabriel Lima Barros de ; Bou-Chacra, Nadia Araci
Source: Biomed Research International. Unidades: FM, FCF
Subjects: LEIHMANIA, NANOPARTÍCULAS, FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MONTEIRO, Lis Marie et al. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. Biomed Research International, v. 2017, p. 11 , 2017Tradução . . Disponível em: https://doi.org/10.1155/2017/9781603. Acesso em: 28 out. 2024.
APA
Monteiro, L. M., Löbenberg, R., Cotrim, P. C., Araujo, G. L. B. de, & Bou-Chacra, N. A. (2017). Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases. Biomed Research International, 2017, 11 . doi:10.1155/2017/9781603
NLM
Monteiro LM, Löbenberg R, Cotrim PC, Araujo GLB de, Bou-Chacra NA. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases [Internet]. Biomed Research International. 2017 ; 2017 11 .[citado 2024 out. 28 ] Available from: https://doi.org/10.1155/2017/9781603
Vancouver
Monteiro LM, Löbenberg R, Cotrim PC, Araujo GLB de, Bou-Chacra NA. Buparvaquone Nanostructured Lipid Carrier: Development of an Affordable Delivery System for the Treatment of Leishmaniases [Internet]. Biomed Research International. 2017 ; 2017 11 .[citado 2024 out. 28 ] Available from: https://doi.org/10.1155/2017/9781603

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Grupo de pesquisa

Funding Agencies

Non normalized affiliation

Countries of institutions of collaboration